Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 70, 2006 - Issue 9
Journal homepage
189
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Anti-Tumor Activities of the Antlered Form of Ganoderma lucidum in Allogeneic and Syngeneic Tumor-Bearing Mice

Yuji NONAKAInstitute for Health Care Science, Suntory Ltd.
,
Hiroshi SHIBATAInstitute for Health Care Science, Suntory Ltd.
,
Masaaki NAKAIInstitute for Health Care Science, Suntory Ltd.
,
Hiroshi KURIHARAInstitute for Health Care Science, Suntory Ltd.
,
Hiroko ISHIBASHIInstitute of Medical Mycology, Teikyo University
,
Yoshinobu KISOInstitute for Health Care Science, Suntory Ltd.
,
Takaharu TANAKAInstitute for Health Care Science, Suntory Ltd.
,
Hideyo YAMAGUCHIInstitute of Medical Mycology, Teikyo University
&
Shigeru ABEInstitute of Medical Mycology, Teikyo University
 show all
Pages 2028-2034 | Received 21 Sep 2005, Accepted 22 May 2006, Published online: 22 May 2014

  • 1) Shiao, M. S., Lee, K. R., Lin, L. J., and Wang, C. T., Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum. In “Food Phytochemicals for Cancer Prevention. II: Teas, Spices, and Herbs,” American Chemical Society, eds. Ho, C. T., Osawa, T., Huang, M. T., and Rosen, R. T., Oxford University Press, Washington, DC, pp. 342–354 (1994).
  • 2) Lee, S. Y., and Rhee, H. M., Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem. Pharm. Bull., 38, 1359–1364 (1990).
  • 3) Kimura, Y., Okuda, H., and Arichi, S., Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. Planta Med., 54, 290–294 (1988).
  • 4) Hikino, H., Ishiyama, M., Suzuki, Y., and Konno, C., Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med., 55, 423–428 (1989).
  • 5) Kabir, Y., Kimura, S., and Tamura, T., Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J. Nutr. Sci. Vitaminol., 34, 433–438 (1988).
  • 6) Park, E. J., Ko, G., Kim, J., and Sohn, D. H., Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol. Pharm. Bull., 20, 417–420 (1997).
  • 7) Kim, D. H., Shim, S. B., Kim, N. J., and Jang, I. S., β-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol. Pharm. Bull., 22, 162–164 (1999).
  • 8) Tasaka, K., Akagi, M., Miyoshi, K., Mio, M., and Makino, T., Anti-allergic constituents in the culture medium of Ganoderma lucidum. I. Inhibitory effect of oleic acid on histamine release. Agents Actions, 23, 153–156 (1988).
  • 9) Tasaka, K., Mio, M., Izushi, K., Akagi, M., and Makino, T., Anti-allergic constituents in the culture medium of Ganoderma lucidum. II. The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions, 23, 157–160 (1988).
  • 10) Sone, Y., Okuda, R., Wada, N., Kishida, E., and Misaki, A., Structures and antitumor activity of the polysaccharides isolated from fruiting body and growing culture of mycelium of Ganoderma lucidum. Agric. Biol. Chem., 49, 2641–2653 (1985).
  • 11) Maruyama, H., Yamazaki, K., Murofushi, S., Konda, C., and Ikekawa, T., Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J. Pharmacobiodyn., 12, 118–123 (1989).
  • 12) Zhang, L., Zhang, M., Zhou, Q., Chen, J., and Zeng, F., Solution properties of antitumor sulfated derivative of α-(1→3)-D-glucan from Ganoderma lucidum. Biosci. Biotechnol. Biochem., 64, 2172–2178 (2000).
  • 13) Bao, X., Liu, C., Fang, J., and Li, X., Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr. Res., 332, 67–74 (2001).
  • 14) Bao, X., Duan, J., Fang, X., and Fang, J., Chemical modifications of the (1→3)-α-D-glucan from spores of Ganoderma lucidum and investigation of their physicochemical properties and immunological activity. Carbohydr. Res., 336, 127–140 (2001).
  • 15) Bao, X., Fang, J., and Li, X., Structural characterization and immunomodulating activity of a complex glucan from spores of Ganoderma lucidum. Biosci. Biotechnol. Biochem., 65, 2384–2391 (2001).
  • 16) Bao, X. F., Zhen, Y., Ruan, L., and Fang, J. N., Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem. Pharm. Bull., 50, 623–629 (2002).
  • 17) Min, B. S., Nakamura, N., Miyashiro, H., Bae, K. W., and Hattori, M., Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull., 46, 1607–1612 (1998).
  • 18) Min, B. S., Gao, J. J., Nakamura, N., and Hattori, M., Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull., 48, 1026–1033 (2000).
  • 19) Gao, J. J., Min, B. S., Ahn, E. N., Nakamura, N., Lee, H. K., and Hattori, M., New triterpene aldehydes, lucialdehydes A–C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem. Pharm. Bull., 50, 837–840 (2002).
  • 20) Ikekawa, T., Beneficial effects of edible and medicinal mushrooms on health care. Int. J. Med. Mushroom, 3, 291–298 (2001).
  • 21) Kohguchi, M., Kunikata, T., Watanabe, H., Kudo, N., Shibuya, T., Ishihara, T., Iwaki, K., Ikeda, M., Fukuda, S., and Kurimoto, M., Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (rokkaku-reishi). Biosci. Biotechnol. Biochem., 68, 881–887 (2004).
  • 22) Ohnishi, M., Kimura, S., Yamazaki, M., Oshima, H., Mizuno, D. I., Abe, S., and Yamaguchi, H., Anti-tumor activity of low-toxicity lipopolysaccharide of Bordetella pertussis. Br. J. Cancer, 69, 1038–1042 (1994).
  • 23) Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S. S., Shiao, M. S., and Ho, C. K., The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer, 70, 699–705 (1997).
  • 24) Bao, X. F., Wang, X. S., Dong, Q., Fang, J. N., and Li, X. Y., Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry, 59, 175–181 (2002).
  • 25) Masuko, Y., Nakajima, H., Tsubouchi, J., Yamazaki, M., Mizuno, D., and Abe, S., Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction. Gann, 73, 790–797 (1982).
  • 26) Abe, S., Yoshioka, O., Masuko, Y., Tsubouchi, J., Kohno, M., Nakajima, H., Yamazaki, M., and Mizono, D., Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors. Gann, 73, 91–96 (1982).
  • 27) Miyaji, C., Ogawa, Y., Imajo, Y., Imanaka, K., and Kimura, S., Combination therapy of radiation and immunomodulators in the treatment of MM 46 tumor transplanted in C3H/He mice. Oncology, 40, 115–119 (1983).
  • 28) Kato, H., Yamamura, Y., Inoue, M., Tanigawa, M., Kimura, S., Sugino, S., and Kondo, M., In vitro augmentation of cytotoxicity by N-CWS in peritoneal polymorphonuclear leukocytes (PMNs) induced by PSK, OK-432 or N-CWS. Biotherapy, 4, 69–73 (1992).
  • 29) Kato, H., Inoue, M., Yamamura, Y., Kawahito, Y., Mukai, S., Sugino, S., and Kondo, M., Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on cytotoxicity of PSK-induced peritoneal polymorphonuclear leukocytes (PMNs). Biotherapy, 5, 177–186 (1992).
  • 30) Sharma, S., Zhu, L., Yang, S. C., Zhang, L., Lin, J., Hillinger, S., Gardner, B., Reckamp, K., Strieter, R. M., Huang, M., Batra, R. K., and Dubinett, S. M., Cyclooxygenase 2 inhibition promotes IFN-γ-dependent enhancement of antitumor responses. J. Immunol., 175, 813–819 (2005).
  • 31) Cryz, S. J., Jr., Furer, E., and Germanier, R., Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect. Immun., 39, 1067–1071 (1983).
  • 32) Gamba-Vitalo, C., DiGiovanna, M. P., and Sartorelli, A. C., Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice. Blood Cells, 17, 193–205 (1991).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.